Amended Statement of Beneficial Ownership (sc 13d/a)
April 01 2020 - 5:03PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13D
(Amendment
No. 2)
Under the Securities Exchange Act of 1934
Daré
Bioscience, Inc.
(Name
of Issuer)
Common
Stock, par value $0.0001 per share
(Title
of Class of Securities)
23666P
101
(CUSIP
Number)
Roger
L. Hawley
16044 Avenida Calma
Rancho Santa Fe, CA 92091
(Name,
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March
27, 2020
(Date
of Event Which Requires Filing of this Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 140.13d-1(g), check the following box. [ ]
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
section 240.13d-7 for other parties to whom copies are to be sent.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
Potential
persons who are to respond to the collection of information contained in this form are not required to respond unless the form
displays a currently valid OMB control number.
|
1.
|
Names
of Reporting Persons
Roger L. Hawley
|
|
|
|
|
2.
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|
4.
|
Source
of Funds (See Instructions)
|
|
PF,
AF, OO
|
|
|
|
|
|
|
5.
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
|
|
6.
|
Citizenship
or Place of Organization
|
|
United
States
|
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
7.
|
Sole
Voting Power
|
1,095,105
(2)
|
8.
|
Shared
Voting Power
|
0
|
9.
|
Sole
Dispositive Power
|
1,095,105
(2)
|
10.
|
Shared
Dispositive Power
|
0
|
|
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
1,095,105 (2)
|
|
|
|
|
|
|
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
|
|
13.
|
Percent
of Class Represented by Amount in Row (11)
|
|
4.4% (3)
|
|
|
|
|
|
|
14.
|
Type
of Reporting Person (See Instructions)
|
|
IN
|
|
|
|
|
|
(1)
|
This
Amendment No. 2 to Schedule 13D is filed by Roger L. Hawley and The Hawley Family Trust Dated October 22, 2004 (the “Trust”
and together, Mr. Hawley, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group”
for purposes of this statement.
|
(2)
|
Consists
of the following shares of Common Stock (i) 140,000 shares held in an individual retirement account for the benefit of Mr.
Hawley, (ii) 944,956 shares held by the Trust, and (iii) 10,149 shares held by Mr. Hawley. Mr. Hawley serves as trustee of
the Trust and holds sole voting and dispositive power over the shares held by the Trust. Mr. Hawley disclaims beneficial ownership
as to the securities held by the Trust, except to the extent of his pecuniary interests therein.
|
(3)
|
This
percentage and other percentage of class reported in this statement are calculated based on 24,690,404 shares of Common Stock
outstanding as of March 26, 2020, as reported by issuer in its annual report on Form 10-K filed with the SEC on March 27,
2020.
|
|
1.
|
Names
of Reporting Persons
The Hawley Family Trust Dated October 22, 2004
|
|
|
|
|
2.
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|
4.
|
Source
of Funds (See Instructions)
|
|
PF,
OO
|
|
|
|
|
|
|
5.
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
|
|
6.
|
Citizenship
or Place of Organization
|
|
California
|
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
7.
|
Sole
Voting Power
|
944,956
(2)
|
8.
|
Shared
Voting Power
|
0
|
9.
|
Sole
Dispositive Power
|
944,956
(2)
|
10.
|
Shared
Dispositive Power
|
0
|
|
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
944,956 (2)
|
|
|
|
|
|
|
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
|
|
13.
|
Percent
of Class Represented by Amount in Row (11)
|
|
4.8%
|
|
|
|
|
|
|
14.
|
Type
of Reporting Person (See Instructions)
|
|
OO
|
|
|
|
|
|
(1)
|
The
Reporting Persons expressly disclaim status as a “group” for purposes of this statement.
|
(2)
|
Mr.
Hawley serves as trustee of the Trust and holds sole voting and dispositive power over the shares held by the Trust. Mr. Hawley
disclaims beneficial ownership as to the securities held by the Trust, except to the extent of his pecuniary interests therein.
|
Preliminary
Note: This Amendment No. 2 to Schedule 13D (this “Amendment”) amends the Schedule 13D originally filed
with the Securities and Exchange Commission (the “SEC”) on July 28, 2017, as amended by Amendment No. 1 thereto
filed with the SEC on April 15, 2019 (as heretofore amended, the “Schedule 13D”).
The
Schedule 13D relates to the shares of common stock, par value $0.0001 per share (the “Common Stock”), of Daré
Bioscience, Inc. (the “Issuer”) owned by the Reporting Persons. Except as specifically amended by this Amendment,
items in the Schedule 13D are unchanged.
This
Amendment reports a decrease in the Reporting Persons’ percentage of beneficial ownership of the outstanding Common Stock
since the date the Reporting Persons’ last filing on Schedule 13D. Capitalized terms used herein that are not defined herein
have the meanings ascribed to them in the Schedule 13D.
Item
2. Identity and Background
Paragraph
(b) and (c) of Item 2 of the Schedule 13D is hereby amended by replacing it in its entirety with:
(b)
Mr. Hawley’s address is 16044 Avenida Calma, Rancho Santa Fe, CA 92091.
(c)
Mr. Hawley resigned from the Issuer’s board of directors and from all of its committees on July 11, 2019. Mr. Hawley is
presently retired.
Item
3. Source and Amount of Funds or Other Consideration
Item
3 of the Schedule 13D is hereby supplemented with:
On
March 30, 2020, Mr. Hawley acquired 10,149 shares of Common Stock upon the exercise of stock options. The exercise price for such
stock options was paid for with his personal funds. Following the acquisition of such shares of Common Stock, the Reporting Persons
beneficially own 1,095,105 shares of Common Stock consisting of: (i) 140,000 shares held in an individual retirement account for
the benefit of Mr. Hawley, (ii) 944,956 shares held by the Trust, and (iii) 10,149 shares held by Mr. Hawley. Mr. Hawley serves
as trustee of the Trust and holds sole voting and dispositive power over the shares held by the Trust. Mr. Hawley disclaims beneficial
ownership as to the securities held by the Trust, except to the extent of his pecuniary interests therein.
Item
4. Purpose of Transaction
Item
4 of the Schedule 13D is hereby supplemented with:
Mr.
Hawley acquired the shares of Common Stock upon the exercise of stock options for investment purposes.
Mr.
Hawley resigned from the Issuer’s board of directors and from all of its committees on July 11, 2019.
Item
5. Interest in Securities of the Issuer
Item
5 of the Schedule 13D is hereby amended by replacing it in its entirety with:
|
(a)
|
Mr.
Hawley may be deemed to beneficially own 1,095,105 shares of Common Stock consisting of: (i) 140,000 shares held in an individual
retirement account for the benefit of Mr. Hawley, (ii) 944,956 shares held by the Trust, and (iii) 10,149 shares held by Mr.
Hawley, representing 4.4% of the outstanding Common Stock as of March 26, 2020, based on 24,690,404 shares of Common Stock
outstanding as of that date.
|
The
Trust beneficially owns 944,956 shares of Common Stock, representing 3.8% of the outstanding Common Stock as of March 26, 2020,
based on 24,690,404 shares of Common Stock outstanding as of that date.
|
(b)
|
Mr.
Hawley holds sole voting and dispositive power over the 1,095,105 shares of Common Stock.
|
|
|
|
|
(c)
|
Since
the date of filing of the Schedule 13D, Mr. Hawley acquired 10,149 shares of Common Stock upon the exercise of stock options.
|
|
|
|
|
(d)
|
Except
as described in this statement, no person has the power to direct the receipt of dividends on or the proceeds of sales of,
the shares of Common Stock owned by the Reporting Persons.
|
|
|
|
|
(e)
|
On
March 27, 2020, the Issuer reported on the facing page of its Form 10-K that 24,690,404 shares of Common Stock were outstanding
as of March 26, 2020. As a result of the increase in the reported number of outstanding shares of Common Stock, the Reporting
Person ceased to be the beneficial owner of more than five percent of the outstanding Common Stock.
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated:
April 1, 2020
|
/s/
Roger L. Hawley
|
|
Roger
L. Hawley
|
|
THE
HAWLEY FAMILY TRUST DATED OCTOBER 22, 2004
|
|
|
|
Dated:
April 1, 2020
|
By:
|
/s/
Roger L. Hawley
|
|
Name:
|
Roger
L. Hawley
|
|
Title:
|
Trustee
|
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Apr 2023 to Apr 2024